Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03535597 · ClinicalTrials.gov registry record · NA
Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access
A NA study of Coronary Artery Disease, sponsored by Memorial Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
- 1
- Study location
NCT03535597: Completed NA study of Coronary Artery Disease, sponsored by Memorial Healthcare System.
NCT03535597 is a NA study of Coronary Artery Disease that has completed, run by Memorial Healthcare System. The registered enrollment target is 355 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03535597, a NA study of Coronary Artery Disease, has completed, sponsored by Memorial Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing radial hemostasis management.
Primary Outcome
Initial successful hemostasis is defined as no evidence of external bleeding from the TRA puncture site or expanding hematoma of the forearm after completion of the above described TR Band® and QuikClot® Radial® pad protocols, without the need for reinflation of air in the TR Band® or reapplication of manual pressure over the QuikClot® Radial® pad secured with either a Coban™ bandage or Tegaderm™ dressing, or use of manual compression over the arteriotomy site.
Conditions Studied
Interventions
- DEVICE Quikclot Radial (QC) Pad
Study Locations (1)
Florida
- Memorial Healthcare System - Hollywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2022-12-28 |
| Phase | NA |
What the finished NCT03535597 record still lists
NCT03535597 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Quikclot Radial (QC) Pad is the first listed.
NCT03535597 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03535597 about?
NCT03535597 is a clinical study titled "Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access". To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing ra...
What is the current status of trial NCT03535597?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2018-08-01. Estimated completion is 2022-12-28.
What conditions does trial NCT03535597 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT03535597?
The interventions under investigation include: Quikclot Radial (QC) Pad (DEVICE).
Who is sponsoring clinical trial NCT03535597?
This trial is sponsored by Memorial Healthcare System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03535597 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03535597's enrollment target sits among peer trials
355 94th of 219 higher than 126 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI